Staff Profile

Introduction

In 2011 I identified the causative mechanisms of type 2 diabetes and showed how these are returned to normal by weight loss. This has led to a series of clinical studies on remission of type 2 diabetes which have also confirmed and extended understanding of the aetiological mechanisms. My role encompasses application of magnetic resonance methodology to clinical medicine, metabolic research in diabetes, clinical outcome research in diabetic pregnancy, prevention of blindness by retinal screening in diabetes, and  teaching in diabetes and obstetric medicine.

Related websites:

The Newcastle Magnetic Resonance Centre:

https://go.ncl.ac.uk/diabetes-reversal

Background

Professor of Medicine and Metabolism, University of Newcastle
Honorary Consultant Physician, Newcastle Acute Hospitals NHS Trust

Roles and Responsibilities

Director of Magnetic Resonance Centre

Honorary Consultant Physician, Newcastle upon Tyne Hospitals NHS Foundation Trust

Qualifications

BSc, MB ChB, MD, FRCP, FRCPE

Previous Positions

Visiting Professor, Yale University, 1990-1991
First Assistant, Metabolic Medicine, Newcastle, 1984-1985
MRC Research Fellow, Newcastle, 1981-1984

Honours and Awards 

Sir Robert W Philip Lecture of The Royal College of Physicians of Edinburgh 2021

Samuel Gee Lecture of The Royal College of Physicians 2017

Harry Keen Rank Nutrition Prize Lecture Diabetes UK 2016

Banting Lecture - Diabetes UK 2012 

Arnold Bloom Lecture – Diabetes UK 2005

Chennai MDRF Gold Medal Oration on Diabetic Retinopathy 2005

Honyman Gillespie Lecture Edinburgh Medical School – 1992

RD Lawrence Lectureship of British Diabetic Association 1991

Albert Renold Fellowship European Association for the Study of Diabetes 1990 91

Samuel Lenard Simpson Fellowship Royal College of Physicians 1990 1991

Croom Lectureship Royal College of Physicians of Edinburgh 1988

Research Interests

Aetiological mechanisms of type 2 diabetes

Clinical studies of remission of type 2 diabetes

Magnetic resonance studies of human metabolism in vivo
Establishment of Newcastle Magnetic Resonance Centre
Insulin action in vivo
Metabolic abnormalities in type 2 diabetes

Other Expertise

Management of pregnancy in type 1, type 2 and gestational diabetes
Management of hyperemesis gravidarum

Funding

MRC and Wellcome project grants
Diabetes UK grants
Other charity and industry funding

Undergraduate Teaching

lectures, seminars and bedside / out-patient teaching

Postgraduate Teaching

Post-clinic discussions
lectures to PRHO's and SHO's
Lectures as part of advanced postgrad courses on Diabetes

Lectures on the new understanding of type 2 diabetes nationally and internationally

• Leslie WS, Ali E, Harris L, Messow CM, Brosnahan NT, Thom G, McCombie EL, Barnes AC, Sattar N, Taylor R, Lean MEJ. Antihypertensive medication needs and blood pressure control with weight loss in the Diabetes Remission Clinical Trial (DiRECT). Diabetologia 2021, 64, 1927-1938.
• Brosnahan N, Leslie W, McCombie L, Barnes A, Thom G, McConnachie A, Messow CM, Sattar N, Taylor R, Lean MEJ. Brief formula low-energy-diet for relapse management during weight loss maintenance in the Diabetes Remission Clinical Trial (DiRECT). Journal of Human Nutrition and Dietetics 2021, 34(3), 472-479.
• Riddle MC, Cefalu WT, Evans PH, Gerstein HC, Nauck MA, Oh WK, Rothberg AE, le Roux CW, Rubino F, Schauer P, Taylor R, Twenefour D. Consensus report: definition and interpretation of remission in type 2 diabetes. Diabetologia 2021, 64, 2359-2366.
• Melhem S, Steven S, Taylor R, Al-Mrabeh A. Effect of Weight Loss by Low-Calorie Diet on Cardiovascular Health in Type 2 Diabetes: An Interventional Cohort Study. Nutrients 2021, 13(5), 1465.
• Marchesini G, Taylor R. Genes and lifestyle: Which of the two is more relevant in driving NAFLD progression?. Digestive and Liver Disease 2021, 53(11), 1433-1434.
• Al-Mrabeh A, Peters C, Hollingsworth KG, Taylor R. Measurement of intraorgan fat and hepatic output of triglycerides in human type 2 diabetes by magnetic resonance and Intralipid infusion techniques. STAR Protocols 2021, 2(1), 100355.
• Taylor R, Ramachandran A, Yancy WS, Forouhi NG. Nutritional basis of type 2 diabetes remission. The BMJ 2021, 374(9), n1449.
• Thom G, Messow C-M, Leslie WS, Barnes AC, Brosnahan N, McCombie L, Al-Mrabeh A, Zhyzhneuskaya S, Welsh P, Sattar N, Taylor R, Lean MEJ. Predictors of type 2 diabetes remission in the Diabetes Remission Clinical Trial (DiRECT). Diabetic Medicine 2021, 38(8), e14395.
• Jesuthasan A, Zhyzhneuskaya S, Peters C, Barnes AC, Hollingsworth KG, Sattar N, Lean MEJ, Taylor R, Al-Mrabeh AH. Sex differences in intraorgan fat levels and hepatic lipid metabolism: implications for cardiovascular health and remission of type 2 diabetes after dietary weight loss. Diabetologia 2021, 65, 226-233.
• Taylor R. Type 2 diabetes and remission: practical management guided by pathophysiology. Journal of Internal Medicine 2021, 289(6), 754-770.
• Al-Mrabeh A, Hollingsworth KG, Shaw JAM, McConnachie A, Sattar N, Lean MEJ, Taylor R. 2-year remission of type 2 diabetes and pancreas morphology: a post-hoc analysis of the DiRECT open-label, cluster-randomised trial. The Lancet: Diabetes & Endocrinology 2020, 8(12), 939-948.
• Al-Mrabeh A, Hollingsworth KG, Shaw JAM, McConnachie A, Sattar N, Lean MEJ, Taylor R. 2-year remission of type 2 diabetes and pancreas morphology: a post-hoc analysis of the DiRECT open-label, cluster-randomised trial. The Lancet Diabetes and Endocrinology 2020, 8(12), 939-948.
• Rehackova L, Araujo-Soares V, Steven S, Adamson AJ, Taylor R, Sniehotta FF. Behaviour change during dietary Type 2 diabetes remission: a longitudinal qualitative evaluation of an intervention using a very low energy diet. Diabetic Medicine 2020, 37(6), 953-962.
• Kusinski LC, Murphy HR, Rolfe EDL, Rennie KL, Griep LMO, Hughes D, Taylor R, Meek CL. Dietary intervention in pregnant women with gestational diabetes; protocol for the digest randomised controlled trial. Nutrients 2020, 12(4), 1165.
• Kusinski LC, Murphy HR, Rolfe EDL, Rennie KL, Oude Griep LM, Hughes D, Taylor R, Meek CL. Erratum: Dietary intervention in pregnant women with gestational diabetes; protocol for the digest randomised controlled trial; Nutrients 2020, 12, 1165. Nutrients 2020, 12(6), 1793.
• Al-Mrabeh A, Zhyzhneuskaya SV, Peters C, Barnes AC, Melhem S, Jesuthasan A, Aribasala B, Hollingsworth KG, Lietz G, Mathers JC, Sattar N, Lean MEJ, Taylor R. Hepatic Lipoprotein Export and Remission of Human Type 2 Diabetes after Weight Loss. Cell Metabolism 2020, 31(2), 233-249.
• Taylor R. Remission of type 2 diabetes by weight loss in a non-white population. The Lancet Diabetes and Endocrinology 2020, 8(6), 458-459.
• Zhyzhneuskaya SV, Al-Mrabeh A, Peters C, Barnes AC, Aribisala B, Hollingsworth KG, McConnachie A, Sattar N, Lean MEJ, Taylor R. Time course of normalisation of functional beta cell capacity in DiRECT after weight loss in type 2 diabetes. Diabetes Care 2020, 43(4), 813-820.
• Preshaw PM, Taylor JJ, Jaedicke KM, De Jager M, Bikker JW, Selten W, Bissett SM, Whall KM, van de Merwe R, Arebi A, Jitprasertwong P, Al-Shawani R, Weaver J, Taylor R, Wassall RR. Treatment of periodontitis reduces systemic inflammation in type 2 diabetes. Journal of Clinical Periodontology 2020, 47(6), 737-746.
• Yiqiao X, Davies A, Briggs A, McCombie L, Martina Messow C, Grieve E, Leslie WS, Taylor R, Lean MEJ. Type 2 diabetes remission: 2 year within-trial and lifetime-horizon cost-effectiveness of the Diabetes Remission Clinical Trial (DiRECT)/Counterweight-Plus weight management programme. Diabetologia 2020, 63, 2112-2122.
• Taylor R. Type 2 diabetes remission: latest evidence for health care professionals. Practical Diabetes 2020, 37(5), 177-182.
• Thom G, McIntosh A, Messow C-M, Leslie WL, Barnes A, Brosnahan N, McCombie L, Malkova D, Al-Mrabeh A, Zhyzhneuskaya S, Welsh P, Sattar N, Taylor R, Lean MEJ. Weight loss-induced increase in fasting ghrelin concentration is a predictor of weight regain: Evidence from the Diabetes Remission Clinical Trial (DiRECT). Diabetes, Obesity and Metabolism 2020, 23(3), 711-719.
• Taylor R. Calorie restriction for long-term remission of type 2 diabetes. Clinical Medicine 2019, 19(1), 37-42.
• Taylor R, Barnes A. Can type 2 diabetes be reversed and how can this best be achieved? James Lind Alliance research priority number one. Diabetic Medicine 2019, 36(3), 308-315.
• Taylor R. Corrigendum: Calorie restriction for long-term remission of type 2 diabetes. Clinical Medicine 2019, 19(2), 192-192.
• Lean MEJ, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L, Peters C, Zhyzhneuskaya S, Al-Mrabeh A, Hollingsworth KG, Rodrigues AM, Rehackova L, Adamson AJ, Sniehotta FF, Mathers JC, Ross HM, McIlvenna Y, Welsh P, Kean S, Ford I, McConnachie A, Messow CM, Sattar N, Taylor R. Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial. Lancet Diabetes & Endocrinology 2019, 7(5), 344-355.
• Bynoe K, Unwin N, Taylor C, Murphy MM, Bartholomew L, Greenidge A, Abed M, Jeyaseelan S, Cobelli C, Dalla Man C, Taylor R. Inducing remission of Type 2 diabetes in the Caribbean: findings from a mixed methods feasibility study of a low-calorie liquid diet-based intervention in Barbados. Diabetic Medicine 2019, 37(11), 1816-1824.
• Taylor R. Life Without Diabetes: The definitive guide to understanding and reversing your Type 2 diabetes. London: Short Books, 2019.
• Zhzhysneuskaya S, Taylor R. Obesity and Type 2 Diabetes. In: Sbraccia P; Finer N, ed. Obesity: Pathogenesis, Diagnosis, and Treatment. Berlin: Springer, 2019.
• Taylor R, Valabhji J, Aveyard P, Paul D. Prevention and reversal of Type 2 diabetes: highlights from a symposium at the 2019 Diabetes UK Annual Professional Conference. Diabetic Medicine 2019, 36(3), 359-365.
• Houghton D, Zalewski P, Hallsworth K, Cassidy S, Thoma C, Avery L, Slomko J, Hardy T, Burt AD, Tiniakos D, Hollingsworth KG, Taylor R, Day CP, Masson S, McPherson S, Anstee QM, Newton JL, Trenell MI. The degree of hepatic steatosis associates with impaired cardiac and autonomic function. Journal of Hepatology 2019, 70(6), 1203-1213.
• Hopkins MD, Taylor R, Lean MEJ. The DiRECT principles: giving Type 2 diabetes remission programmes the best chance of success. Diabetic Medicine 2019, 36(12), 1703-1704.
• Xin Y, Davies A, McCombie L, Briggs A, Messow C-M, Grieve E, Leslie WS, Taylor R, Lean MEJ. Type 2 diabetes remission: economic evaluation of the DiRECT/Counterweight-Plus weight management programme within a primary care randomized controlled trial. Diabetic Medicine 2019, 36(8), 1003-1012.
• Taylor R, Al-Mrabeh A, Sattar N. Understanding the mechanisms of reversal of type 2 diabetes. The Lancet Diabetes & Endocrinology 2019, 7(9), 726-736.
• Taylor R, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L, Sattar N, Welsh P, Peters C, Zhyzhneuskaya S, Hollingsworth KG, AlMrabeh A, Rodrigues AM, Rehackova L, Adamson AJ, Sniehotta FF, Mathers JC, Ross HM, McIlvenna Y, Kean S, Ford I, McConachie A, Lean MEJ. Clinical and metabolic features of the randomised controlled Diabetes Remission Clinical Trial (DiRECT) cohort. Diabetologia 2018, 61(3), 589-598.
• Forouhi NG, Misra A, Mohan V, Taylor R, Yancy W. Dietary and nutritional approaches for prevention and management of type 2 diabetes. BMJ 2018, 361, k2234.
• Lean MEJ, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L, Peters C, Zhyzhneuskaya S, Al-Mrabeh A, Hollingsworth KG, Rodrigues AM, Rehackova L, Adamson AJ, Sniehotta FF, Mathers JC, Ross HM, McIlvenna Y, Stefanetti R, Trenell MI, Welsh P, Kean S, Ford I, McConnachie A, Sattar N, Taylor R. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. The Lancet 2018, 391(10120), 541-551.
• Taylor R, Al-Mrabeh A, Zhyzhneuskaya S, Peters C, Barnes AC, Aribisala BS, Hollingsworth KG, Mathers JC, Sattar N, Lean MEJ. Remission of Human Type 2 Diabetes Requires Decrease in Liver and Pancreas Fat Content but Is Dependent upon Capacity for β Cell Recovery. Cell Metabolism 2018, 28(4), 547-556.
• Taylor R, Barnes AC. Translating aetiological insight into sustainable management of type 2 diabetes. Diabetologia 2018, 61(2), 273-283.
• McParlin C, Hodson K, Barnes AC, Taylor R, Robson SC, Araujo-Soares V. Views, experience and adherence of pregnant women participating in a study of weight loss in gestational diabetes (WELLBABE). Diabetic Medicine 2018, 36(2), 195-202.
• Taylor R, Adamson AJ, Sattar N, Lean MEJ, Mathers JC. VLCD for weight loss and remission of type 2 diabetes? – Authors' reply. The Lancet 2018, 392(10155), 1307-1307.
• Rehackova L, Araújo-Soares V, Adamson AJ, Steven S, Taylor R, Sniehotta FF. Acceptability of a very-low-energy diet in Type 2 diabetes: patient experiences and behaviour regulation. Diabetic Medicine 2017, 34(11), 1554-1567.
• McCombie L, Leslie W, Taylor R, Kennon B, Sattar N, Lean MEAJ. Beating type 2 diabetes into remission. BMJ 2017, 358(8121), j4030.
• Houghton D, Hallsworth K, Thoma C, Cassidy S, Hardy T, Heaps S, Hollingsworth KG, Taylor R, Day CP, Masson S, McPherson S, Anstee QM, Trenell MI. Effects of Exercise on Liver Fat and Metabolism in Alcohol Drinkers. Clinical Gastroenterology and Hepatology 2017, 15(10), 1596-1603.e3.
• Houghton D, Thoma C, Hallsworth K, Cassidy S, Hardy T, Burt AD, Tiniakos D, Hollingsworth KG, Taylor R, Day CP, McPherson S, Anstee QM, Trenell MI. Exercise Reduces Liver Lipids and Visceral Adiposity in Patients With Nonalcoholic Steatohepatitis in a Randomized Controlled Trial. Clinical Gastroenterology and Hepatology 2017, 15(1), 96-102.e3.
• Hodson K, Dalla Man C, Smith FE, Barnes A, McParlin C, Cobelli C, Robson SC, Araújo-Soares V, Taylor R. Liver triacylglycerol content and gestational diabetes: effects of moderate energy restriction. Diabetologia 2017, 60(2), 306-313.
• Taylor R. Putting insulin resistance into context by dietary reversal of type 2 diabetes. Journal of the Royal College of Physicians of Edinburgh 2017, 47(2), 168-171.
• Al-Mrabeh A, Hollingsworth KG, Steven S, Tiniakos D, Taylor R. Quantification of intrapancreatic fat in type 2 diabetes by MRI. PLOS One 2017, 12(4), e0174660.
• Leslie WS, Taylor R, Harris L, Lean MEJ. Weight losses with low-energy formula diets in obese patients with and without type 2 diabetes: Systematic review and meta-analysis. International Journal of Obesity 2017, 41(1), 96-101.
• Mann, LW, Higgins, DM, Peters, CN, Cassidy, S, Hodson, KK, Coombs, A, Taylor, R, Hollingsworth KG. Accelerating MR Imaging Liver Steatosis Measurement Using Combined Compressed Sensing and Parallel Imaging: A Quantitative Evaluation. Radiology 2016, 278(1), 247-256.
• Steven S, Hollingsworth KG, Small PK, Woodcock SA, Pucci A, Aribasala B, Al-Mrabeh A, Batterham RL, Taylor R. Calorie restriction and not glucagon-like peptide-1 explains the acute improvement in glucose control after gastric bypass in Type 2 diabetes. Diabetic Medicine 2016, 33(12), 1723-1731.
• Taylor R. Calorie restriction and reversal of type 2 diabetes. Expert Review of Endocrinology and Metabolism 2016, 11(6), 521-528.
• Avery L, Mostafaee B, Charman S, Taylor R, Sniehotta F, Trenell M. Can a behavioural intervention targeting physical activity behaviour of adults with type 2 diabetes be delivered faithfully by healthcare professionals during routine primary care?. In: Diabetes UK Professional Conference 2016. 2016, Glasgow, UK: Wiley.
• Avery L, Mostafaee B, Charman SJ, Taylor R, Sniehotta FF, Trenell MI. Can a behavioural intervention targeting physical activity behaviour of adults with Type 2 diabetes be delivered faithfully by healthcare professionals during routine primary care?. In: Diabetes UK Professional Conference 2016. 2016, Glasgow: Wiley-Blackwell Publishing Ltd.
• Leslie W, Lean M, Brosnahan N, Barnes A, Thom G, Sattar N, McCombie L, Ross H, Taylor R. Diabetes Remission Clinical Trial (DiRECT): protocol for a cluster randomised controlled trial in primary care. In: Diabetes UK Professional Conference 2016. 2016, Glasgow: Wiley-Blackwell Publishing Ltd.
• Rehackova L, Arnott B, Araujo-Soares V, Adamson AJ, Taylor R, Sniehotta FF. Efficacy and acceptability of very low energy diets in overweight and obese people with Type 2 diabetes mellitus: a systematic review with meta-analyses. Diabetic Medicine 2016, 33(5), 580-591.
• Houghton DH, Thoma CT, Cassidy SC, Hallsworth KH, Hollingsworth KGH, Taylor RT, Day CPD, Anstee QMA, Trenell MIT. Exercise reduces liver fat and improves body composition but not insulin sensitivity or inflammatory markers in non-alcoholic steatohepatitis. In: Diabetes UK Professional Conference. 2016, Glasgow: Wiley-Blackwell Publishing Ltd.
• Cassidy S, Thoma C, Hallsworth K, Parikh J, Hollingsworth KG, Taylor R, Jakovljevic DG, Trenell MI. High intensity intermittent exercise improves cardiac structure and function and reduces liver fat in patients with type 2 diabetes: a randomised controlled trial. Diabetologia 2016, 59(1), 56-66.
• Al-Mrabeh A, Hollingsworth KG, Steven S, Taylor R. Morphology of the pancreas in type 2 diabetes: effect of weight loss with or without normalisation of insulin secretory capacity. Diabetologia 2016, 59(8), 1753–1759.
• Avery L, Charman SJ, Catt M, Taylor R, Sniehotta FF, Trenell MI. Movement as medicine for type 2 diabetes: a clustered pilot randomised controlled trial of a theory-informed multifaceted behavioural intervention to increase physical activity of adults with type 2 diabetes in the primary care setting. In: International Conference of Behavioral Medicine. 2016, Melbourne, Australia: Springer.
• Fuchs C, Gonzalez J, Beelen M, Cermak N, Smith F, Thelwall PE, Taylor R, Trenell M, Stevenson E, van Loon L. Sucrose ingestion after exhaustive exercise accelerates liver, but not muscle glycogen repletion when compared to glucose ingestion in trained athletes. Journal of Applied Physiology 2016, 120(11), 1328-1334.
• Avery L, Charman S, Taylor L, Flynn D, Mosely K, Speight J, Lievesley M, Taylor R, Sniehotta F, Trenell M. Systematic development of a theory-informed multifaceted behavioral intervention to increase physical activity of adults with type 2 diabetes in routine primary care: movement as medicine for type 2 diabetes. In: International Congress of Behavioural Medicine ICBM 2016. 2016, Melbourne: Springer New York LLC.
• Avery L, Charman SJ, Taylor L, Flynn D, Mosely K, Speight J, Lievesley M, Taylor R, Sniehotta FF, Trenell MI. Systematic development of a theory-informed multifaceted behavioural intervention to increase physical activity of adults with Type 2 diabetes in routine primary care: Movement as Medicine for Type 2 Diabetes. Implementation Science 2016, 11, 99.
• Leslie WS, Ford I, Sattar N, Hollingsworth KG, Adamson A, Sniehotta FF, McCombie L, Brosnahan N, Ross H, Mathers JC, Peters C, Thom G, Barnes A, Kean S, McIlvenna Y, Rodrigues A, Rehackova L, Zhyzhneuskaya S, Taylor R, Lean MEJ. The Diabetes Remission Clinical Trial (DiRECT): protocol for a cluster randomised trial. BMC Family Practice 2016, 17, 20.
• White MG, Shaw JAM, Taylor R. Type 2 Diabetes: The Pathologic Basis of Reversible β-Cell Dysfunction. Diabetes Care 2016, 39(11), 2080-2088.
• Steven S, Hollingsworth KG, Al-Mrabeh A, Avery L, Aribisala B, Caslake M, Taylor R. Very-Low-Calorie Diet and 6 Months of Weight Stability in Type 2 Diabetes: Pathophysiological Changes in Responders and Nonresponders. Diabetes Care 2016, 39(5), 808-815.
• Steven S, Hollingsworth KG, Small PK, Woodcock SA, Pucci A, Aribisala B, Al-Mrabeh A, Daly AK, Batterham RL, Taylor R. Weight Loss Decreases Excess Pancreatic Triacylglycerol Specifically in Type 2 Diabetes. Diabetes Care 2016, 39(1), 158-165.
• Hodson K, McParlin C, Araujo-Soares V, Robson S, Taylor R. WEight Loss Looking for BAbe and mother's BEtter outcome (WELLBABE) study. In: British Maternal & Fetal Medicine Society (BMFMS) 18th Annual Conference. 2016, Birmingham: Wiley-Blackwell Publishing Ltd.
• McParlin C, Araujo-Soares V, Hodson K, Taylor R, Robson S. Women's experience of participating in a reduced calorie diet following diagnosis of gestational diabetes. In: British Maternal & Fetal Medicine Society (BMFMS) 18th Annual Conference. 2016, Birmingham: Wiley-Blackwell Publishing Ltd.
• Rehackova LR, Araujo-Soares V, Adamson AA, Steven S, Taylor R, Sniehotta FF. A qualitative process evaluation of a diabetes remission programme using very low energy diets. In: "Celebrating the Past, Looking Toward the Future": 50th Annual Conference of the Australian Psychological Society. 2015, Queensland, Australia: Australian Psychological Society Limited.
• Macauley M, Percival K, Thelwall PE, Hollingsworth KG, Taylor R. Altered Volume, Morphology and Composition of the Pancreas in Type 2 Diabetes. PLOS One 2015, 10(5), e0126825.
• Cassidy S, Hallsworth K, Thoma C, MacGowan GA, Hollingsworth KG, Day CP, Taylor R, Jakovljevic DG, Trenell MI. Cardiac structure and function are altered in type 2 diabetes and Non-alcoholic fatty liver disease and associate with glycemic control. Cardiovascular Diabetology 2015, 14, 23.
• Peters C, Steven S, Taylor R. Case 73: Reversal of Type 2 Diabetes by Weight Loss Despite Presence of Macro- and Microvascular Complications. In: Diabetes Case Studies: Real Problems, Practical Solutions. American Diabetes Association, 2015, pp.271-274.
• Macauley M, Smith FE, Thelwall PE, Hollingsworth KG, Taylor R. Diurnal variation in skeletal muscle and liver glycogen in humans with normal health and Type 2 diabetes. Clinical Science 2015, 128(10), 707-713.
• Jakovljevic DG, Papakonstantinou L, Blamire AM, MacGowan GA, Taylor R, Hollingsworth KG, Trenell MI. Effect of Physical Activity on Age-Related Changes in Cardiac Function and Performance in Women. Circulation: Cardiovascular Imaging 2015, 8, e002086.
• Macauley M, Hollingsworth KG, Smith FE, Thelwall PE, Al-Mrabeh A, Schweizer A, Foley JE, Taylor R. Effect of Vildagliptin on Hepatic Steatosis. Journal of Clinical Endocrinology & Metabolism 2015, 100(4), 1578-1585.
• Peters C, Taylor R. Gastroparesis and pregnancy. In: Diabetes case studies: Real Problems, Practical Solutions. Alexandria: American Diabetes Association, 2015, pp.378-380.
• Cassidy S, Thoma C, Hallsworth K, Parikh J, Hollingsworth KG, Day CP, Jakovljevic DG, Taylor R, Trenell MI. High intensity intermittent training improves cardiac function and reduces liver fat in adults with Type 2 diabetes: an MRI/S study. In: Diabetes UK Professional Conference. 2015, London, UK: Wiley-Blackwell Publishing Ltd.
• Gonzalez JT, Fuchs CJ, Smith FE, Thelwall PE, Taylor R, Stevenson EJ, Trenell MI, Cermak NM, van Loon LJC. Ingestion of glucose or sucrose prevents liver but not muscle glycogen depletion during prolonged endurance-type exercise in trained cyclists. American Journal of Physiology Endocrinology and Metabolism 2015, 309(12), E1032-E1039.
• Madathil A, Hollingsworth KG, Blamire AM, Razvi S, Newton JL, Taylor R, Weaver JU. Levothyroxine Improves Abnormal Cardiac Bioenergetics in Subclinical Hypothyroidism: A Cardiac Magnetic Resonance Spectroscopic Study. Journal of Clinical Endocrinology and Metabolism 2015, 100(4), E607-E610.
• Vincent A, Rocha M, Rygiel K, Grady J, Campbell G, Barresi R, Taylor R, Turnbull D. Mitochondrial dysfunction: A key player in myofibrillar myopathy?. In: 20th International Congress of the World Muscle Society. 2015, London, UK: Elsevier.
• Talks SJ, Manjunath V, Steel DHW, Peto T, Taylor R. New vessels detected on wide-field imaging compared to two-field and seven-field imaging: implications for diabetic retinopathy screening image analysis. British Journal of Ophthalmology 2015, 99(12), 1606-1609.
• Taylor R, Holman RR. Normal weight individuals who develop Type 2 diabetes: the personal fat threshold. Clinical Science 2015, 128(7), 405-410.
• Hollingsworth KG, Al-Mrabeh A, Steven S, Taylor R. Pancreatic triacylglycerol distribution in type 2 diabetes. Diabetologia 2015, 58(11), 2676-2678.
• Steven S, Taylor R. Restoring normoglycaemia by use of a very low calorie diet in long- and short-duration Type 2 diabetes. Diabetic Medicine 2015, 32(9), 1149-1155.
• Steven S, Carey PE, Small PK, Taylor R. Reversal of Type 2 diabetes after bariatric surgery is determined by the degree of achieved weight loss in both short- and long-duration diabetes. Diabetic Medicine 2015, 32(1), 47-53.
• Steven S, Taylor R. The glycaemic and anti-hypertensive effects of a very low calorie diet are maintained over 6 months in both short- and long-duration Type 2 diabetes. In: Diabetes UK Professional Conference 2015. 2015, London, UK: Wiley-Blackwell Publishing Ltd.
• Leslie W, Taylor R, Lean M. Weight Loss with Liquid Formula Diets in Obese Patients with and without Diabetes. In: Experimental Biology 2015. 2015, Boston, MA, USA: Federation of American Societies for Experimental Biology.
• Steven S, Small PK, Woodcock S, Hollingsworth KG, Taylor R. Direct comparison of the early change in fasting glucose levels after Roux-en-Y gastric bypass surgery or very low calorie diet. In: Diabetes UK Professional Conference 2014. 2014, Liverpool, UK: Wiley-Blackwell.
• Jakovljevic DG, Papakonstantinou L, Blamire AM, MacGowan GA, Taylor R, Hollingsworth KG, Trenell MI. Effect of physical activity on age-related changes in cardiac function and performance in women. Circulation: Cardiovascular Imaging 2014, 8(1), e002086.
• Jakovljevic DG, Papakonstantinou L, Blamire AM, MacGowan GA, Taylor R, Hollingsworth KG, Trenell MI. Effect of physical activity on age-related changes in cardiac function and performance in women. Circulation: Cardiovascular Imaging 2014.
• Macauley MEO, Smith FE, Helwall P, Taylor R. Failure of the skeletal muscle to contribute to diurnal glucose homeostasis in type 2 diabetes. In: 50th General Assembly of the European Association for the Study of Diabetes. 2014, Vienna, Austria: Springer.
• Hodson KK, MacDougall MWJ, Taylor R. Gestational Diabetes: Treating gestational diabetes reduces perinatal morbidity. British Medical Journal 2014, 348, g2690.
• Steven S, Taylor R. Glucose lowering and anti-hypertensive effects of a very low calorie diet: comparison of response in short and long duration Type 2 diabetes. In: Diabetes UK Professional Conference 2014. 2014, Liverpool, UK: Wiley-Blackwell.
• Cassidy SA, Thoma C, Hallsworth K, Jakovljevic DG, Parikh J, Hollingsworth KG, Taylor R, Trenell MI. High intensity intermittent exercise reverses abnormal cardiac function in people with type 2 diabetes: an MRI/S study. In: 50th General Assembly of the European Association for the Study of Diabetes. 2014, Vienna, Austria: Springer.
• Avery L, Sniehotta FF, Denton SJ, Steen N, McColl E, Taylor R, Trenell MI. Movement as Medicine for Type 2 Diabetes: Protocol for an open pilot study and external pilot clustered randomised controlled trial to assess acceptability, feasibility and fidelity of a multifaceted behavioural intervention targeting physical activity in primary care. Trials 2014, 15(46), 1-18.
• Hallsworth K, Thoma C, Moore S, Ploetz T, Anstee QM, Taylor R, Day CP, Trenell MI. Non-alcoholic fatty liver disease is associated with higher levels of objectively measured sedentary behaviour and lower levels of physical activity than matched healthy controls. Frontline Gastroenterology 2014, 1-8.
• Skamarauskas JT, Oakley F, Smith FE, Bawn C, Dunn M, Vidler DS, Clemence M, Blain PG, Taylor R, Gamcsik MP, Thelwall PE. Non-invasive in vivo magnetic resonance measures of glutathione synthesis in human and rat liver as an oxidative stress biomarker. Hepatology 2014, 59(6), 2321-2330.
• Macauley M, Percival K, Thelwall P, Hollingsworth K, Taylor R. Precise non-invasive quantification of pancreas volume and relationship with insulin secretion in Type 2 diabetes. In: Diabetes UK Professional Conference 2014. 2014, Liverpool, UK: Wiley-Blackwell.
• Percival K, Macauley M, Steven S, Lim EL, Hollingsworth KG, Taylor R. Relationship between fat accumulation in liver and pancreas in Type 2 diabetes and normoglycaemia. In: Diabetes UK Professional Conference 2014. 2014, Liverpool, UK: Wiley-Blackwell.
• Little SA, MacDougall MWJ, Taylor R, Marshall SM. Are steroids really necessary in women with diabetes delivering by elective caesarean section prior to 39 weeks' gestation?. In: Diabetes UK Professional Conference 2013. 2013, Manchester, UK: Wiley-Blackwell.
• Taylor R. Banting Memorial Lecture 2012 Reversing the twin cycles of Type 2 diabetes. Diabetic Medicine 2013, 30(3), 267-275.
• Hallsworth K, Hollingsworth KG, Thoma C, Jakovljevic DG, MacGowan GA, Anstee QM, Day CP, Taylor R, Trenell MI. Cardiac function improves following high intensity intermittent exercise in adults with non-alcoholic fatty liver disease. In: Diabetes UK Annual Professional Conference. 2013, Manchester, UK: Diabetes UK.
• Hallsworth K, Hollingsworth KG, Thoma C, Jakovljevic D, MacGowan GA, Anstee QM, Day CP, Taylor R, Trenell MI. Cardiac function improves following high intensity intermittent exercise in adults with non-alcoholic fatty liver disease. In: Diabetes UK Professional Conference 2013. 2013, Manchester, UK: Wiley-Blackwell.
• Hallsworth K, Hollingsworth KG, Thoma C, Jakovljevic DG, MacGowan GA, Anstee QM, Taylor R, Day CP, Trenell MI. Cardiac structure and function are altered in adults with non-alcoholic fatty liver disease. Journal of Hepatology 2013, 58(4), 757-762.
• Taylor R. Effective Management of Severe Vomiting in Pregnancy. Physician 2013, 2(1).
• Thelwall PE, Smith FE, Leavitt M, Hu W, Hollingsworth KG, Thoma C, Trenell MI, Taylor R, Rutkowski JV, Blamire AM, Quinn AG. Hepatic cholesteryl ester accumulation in lysosomal acid lipase deficiency: Non-invasive identification and treatment monitoring by magnetic resonance. In: 48th Annual meeting of the European Association for the Study of the Liver. 2013, Amsterdam, Netherlands: Elsevier BV.
• Thelwall PE, Smith FE, Leavitt MC, Canty D, Hu W, Hollingsworth KG, Thoma C, Trenell MI, Taylor R, Rutkowski JV, Blamire AM, Quinn AG. Hepatic Cholesteryl Ester Accumulation in Lysosomal Acid Lipase Deficiency: Non-Invasive Identification and Treatment Monitoring by Magnetic Resonance. Journal of Hepatology 2013, 59(3), 543-549.
• Hodson K, Man CD, Smith FE, Thelwall PE, Cobelli C, Robson SC, Taylor R. Mechanism of Insulin Resistance in Normal Pregnancy. HORMONE AND METABOLIC RESEARCH 2013, 45(8), 567-571.
• Knop FK, Taylor R. Mechanism of Metabolic Advantages After Bariatric Surgery: It's all gastrointestinal factors versus it's all food restriction. Diabetes Care 2013, 36(Suppl. 2), S287-S291.
• Taylor R. Things that go bump in the night. Diabetic Medicine 2013, 30(8), 889-890.
• Taylor R. Type 2 Diabetes Etiology and reversibility. Diabetes 2013, 36(4), 1047-1055.
• Thoma C, Hallsworth K, Hollingsworth K, Taylor R, Day CP, Trenell M. Unsupervised high-intensity intermittent training reduces liver fat and improves body composition in adults with non-alcoholic fatty liver disease (NAFLD). In: Diabetes UK Professional Conference 2013. 2013, Manchester, UK: Wiley-Blackwell.
• Taylor R. Banting Memorial Lecture 2012 Reversing the twin cycles of Type 2 diabetes. Diabetic Medicine 2012, 30(3), 267-275.
• Hallsworth K, Hollingsworth KG, Thoma C, Taylor R, Day CP, Trenell MI. Cardiac structure and function are altered in adults with non-alcoholic fatty liver disease. In: 47th Annual Meeting of the European Association for the Study of the Liver (EASL). 2012, Barcelona, Spain: Elsevier BV.
• Hallsworth K, Hollingsworth KG, Thoma C, Taylor R, Day CP, Trenell MI. Cardiac structure and function is altered in adults with non-alcoholic fatty liver disease. In: EuroPRevent: The European Society of Cardiology Congress. 2012, Dublin, Ireland.
• Hollingsworth KG, Macgowan GA, Morris L, Bates MG, Taylor R, Jones DE, Newton JL, Blamire AM. Cardiac torsion-strain relationships in fatigued primary biliary cirrhosis patients show accelerated aging: a pilot cross-sectional study. Journal of Applied Physiology 2012, 112(12), 2043-2048.
• Taylor R. Insulin Resistance and Type 2 Diabetes. Diabetes 2012, 61(4), 778-779.
• Hallsworth K, Thoma C, Moore S, Taylor R, Day CP, Trenell MI. Physical activity levels are lower in people with non-alcoholic fatty liver disease than matched healthy controls. In: Diabetes UK Annual Professional Conference. 2012, Glasgow, UK.
• Steven S, Coates JA, Ogilvie P, Carey PE, Small PK, Taylor R. Reversal of type 2 diabetes following gastric bypass surgery is determined by the degree of achieved weight loss and is not limited by disease duration. In: 48th General Assembly of the European Association for the Study of Diabetes. 2012, Berlin, Germany: Springer.
• Lim EL, Hollingsworth KG, Smith FE, Thelwall PE, Taylor R. Effects of raising muscle glycogen synthesis rate on skeletal muscle ATP turnover rate in type 2 diabetes. American Journal of Physiology: Endocrinology and Metabolism 2011, 301(6), E1155.
• Lim EL, Hollingsworth KG, Aribisala BS, Chen MJ, Mathers JC, Taylor R. Fasting Successfully Treats Early Diabetes Type 2. Forschende Komplementaermedizin 2011, 18(6), 359-360.
• Lim EL, Hollingsworth KG, Smith F, Thelwall P, Taylor R. Inhibition of lipolysis in type 2 diabetes normalizes glucose disposal without change in muscle glycogen synthesis rates. Clinical Science 2011, 121(4), 169-177.
• Hallsworth K, Fattakhova G, Hollingsworth KG, Thoma C, Moore S, Day CP, Taylor R, Trenell MI. Resistance exercise improves liver fat and glucose control in people with non-alcoholic fatty liver disease. In: 47th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD). 2011, Lisbon, Portugal: EASD.
• Hallsworth K, Fattakhova G, Hollingsworth KG, Thoma C, Moore S, Taylor R, Day CP, Trenell MI. Resistance exercise improves liver fat and glucose control in people with non-alcoholic fatty liver disease. In: Chartered Society of Physiotherapy Annual Congress. 2011, Liverpool, UK.
• Hallsworth K, Fattakhova G, Hollingsworth KG, Thoma C, Moore S, Taylor R, Day CP, Trenell MI. Resistance exercise improves liver fat and glucose control in people with non-alcoholic fatty liver disease. In: Diabetes UK Annual Professional Conference. 2011, London, UK.
• Hallsworth K, Fattakhova G, Hollingsworth KG, Thoma C, Moore S, Taylor R, Day CP, Trenell MI. Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss. Gut 2011, 60(9), 1278-1283.
• Lim EL, Hollingsworth KG, Aribisala BS, Chen MJ, Mathers JC, Taylor R. Reversal of type 2 diabetes: Normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia 2011, 54(10), 2506-2514.
• Taylor R. Reversing Type 2 diabetes. Practical Diabetes 2011, 28(9), 377-378.
• Taylor R. Balancing fear of hypoglycaemia with optimal control in pregnancy. In: Stephen Gough, Susan Manley, Irene Stratton, ed. HbA1c in Diabetes: Case Studies using IFCC Units. Wiley-Blackwell, 2010, pp.69-69.
• Balasubramanian R, Gerrard J, Dalla Man C, Firbank MJ, Lane A, English PT, Cobelli C, Taylor R. Combination peroxisome proliferator-activated receptor gamma and alpha agonist treatment in Type 2 diabetes prevents the beneficial pioglitazone effect on liver fat content. Diabetic Medicine 2010, 27(2), 150-156.
• Steven S, Lim EL, Taylor R. Dietary reversal of Type 2 diabetes motivated by research knowledge. Diabetic Medicine 2010, 27(6), 724-725.
• Hodson K, Robson K, Taylor R. Gestational diabetes: emerging concepts in pathophysiology. Obstetric Medicine 2010, 3(4), 128-132.
• Hollingsworth KG, Newton JL, Patanwala I, Taylor R, Blamire AM, Jones DE. Impaired subendocardial myofibre in primary biliary cirrhosis. In: 61st Annual Meeting of the American Association for the Study of Liver Diseases. 2010, Boston, MA: Hepatology: Wiley-Blackwell.
• Lim EL, Hollingsworth KG, Thelwall PE, Taylor R. Measuring the acute effect of insulin infusion on ATP turnover rate in human skeletal muscle using phosphorus-31 magnetic resonance saturation transfer spectroscopy. NMR in Biomedicine 2010, 23(8), 952-957.
• Chen MJ, Jovanovic A, Taylor R. Utilizing the Second-Meal Effect in Type 2 Diabetes: Practical Use of a Soya-Yogurt Snack. Diabetes Care 2010, 33(12), 2552-2554.
• Arun CS, Al-Bermani A, Stannard K, Taylor R. Long-term impact of retinal screening on significant diabetes-related visual impairment in the working age population. Diabetic Medicine 2009, 26(5), 489-492.
• Al-Ozairi E, Waugh JJS, Taylor R. Termination is not the treatment of choice for severe hyperemesis gravidarum: Successful management using prednisolone. Obstetric Medicine 2009, 2(1), 34-37.
• Jovanovic A, Gerrard J, Taylor R. The Second-Meal Phenomenon in Type 2 Diabetes. Diabetes Care 2009, 32(7), 1199-1201.
• Jovanovic A, Leverton E, Solanky B, Ravikumar B, Snaar JEM, Morris PG, Taylor R. The second-meal phenomenon is associated with enhanced muscle glycogen storage in humans. Clinical Science 2009, 117(3), 119-127.
• Savage D, Zhai L, Ravikumar B, Cheol S, Snaar J, McGuire A, Wou S, Medina-Gomez G, Kim S, Bock C, Segvich D, Vidal-Puig A, Wareham N, Shulman G, Karpe F, Taylor R, Pederson B, Roach P, O'Rahilly S, DePaoli-Roach A. A prevalent variant in PPP1R3A impairs glycogen synthesis and reduces muscle glycogen content in humans and mice. PLoS Medicine 2008, 5(1), e27.
• Trenell MI, Hollingsworth KG, Lim EL, Taylor R. Increased daily walking improves lipid oxidation without changes in mitochondrial function in type 2 diabetes. Diabetes Care 2008, 31(8), 1644-1649.
• Arun CS, Taylor R. Influence of pregnancy on long-term progression of retinopathy in patients with type 1 diabetes. Diabetologia 2008, 51(6), 1041-1045.
• Fraser H, Preshaw PM, Taylor R, Weaver JU, Wassall RR. Oral Hygiene and Periodontal Health in Type 1 Diabetes Patients. In: IADR 86th General Session. 2008, Toronto: International Association for Dental Research.
• Taylor R. Pathogenesis of type 2 diabetes: Tracing the reverse route from cure to cause. Diabetologia 2008, 51(10), 1781-1789.
• Hollingsworth KG, Newton JL, Taylor R, McDonald C, Palmer JM, Blamire AM, Jones DEJ. Pilot Study of Peripheral Muscle Function in Primary Biliary Cirrhosis: Potential Implications for Fatigue Pathogenesis. Clinical Gastroenterology and Hepatology 2008, 6(9), 1041-1048.
• Ravikumar B, Gerrard J, Man CD, Firbank MJ, Lane A, English PT, Cobelli C, Taylor R. Pioglitazone decreases fasting and postprandial endogenous glucose production in proportion to decrease in hepatic triglyceride content. Diabetes 2008, 57(9), 2288-2295.
• Trenell MI, Hollingsworth KG, Lim EL, Taylor R. Walking improves lipid oxidation independent of changes in mitochondrial ATP synthesis in people with Type 2 diabetes. Diabetes Care 2008, 31(8), 1644-1649.
• Ravikumar B, Gerrard J, English PT, Firbank MJ, Taylor R. Combination therapy with PPARgamma and PPARalpha agonists in Type 2 diabetes improves glucose and lipid metabolism independent of changes in tissue triglyceride content. Diabetic Medicine 2007, 24, 43-43.
• Al-Bermani A, Taylor R. Techniques for investigation of the eye in diabetes. In: M Roden, ed. Clinical Diabetes Research: Methods and Techniques. Chichester: John Wiley & Sons, 2007, pp.342-366.
• Taylor R. Digami too?. Diabetologia 2006, 49(6), 1134-1137.
• Arun CS, Young D, Batey D, Shotton M, Mitchie D, Stannard KP, Taylor R. Establishing ongoing quality assurance in a retinal screening programme. Diabetic Medicine 2006, 23(6), 629-634.
• Taylor R. Handbook of Retinal Screening in Diabetes. London: Wiley-Blackwell, 2006.
• Carey PE, Gerrard J, Cline GW, Dalla Man C, English PT, Firbank MJ, Cobelli C, Taylor R. Acute inhibition of lipolysis does not affect postprandial suppression of endogenous glucose production. American Journal of Physiology - Endocrinology and Metabolism 2005, 289(6), E941-E947.
• Singhal P, Caumo A, Cobelli C, Taylor R. Effect of repaglinide and gliclazide on postprandial control of endogenous glucose production. Metabolism 2005, 54(1), 79-84.
• Al-Bermani A, Desha YH, Morgan J, Soobrah R, Symonds CS, Taylor R. Management of incidental hyperglycaemia in acute medical emergencies. Diabetic Medicine 2005, 22(7), 937-941.
• Ravikumar B, Carey PE, Snaar JEM, Deelchand DK, Cook DB, Neely RDG, English PT, Firbank MJ, Morris PG, Taylor R. Real-time assessment of postprandial fat storage in liver and skeletal muscle in health and type 2 diabetes. American Journal of Physiology: Endocrinology and Metabolism 2005, 288(4), E789-E797.
• Taylor R. Causation of Type 2 Diabetes - The Gordian Knot Unravels. New England Journal of Medicine 2004, 350(7), 639-641.
• Basu A, Dillon RDS, Marshall SM, Taylor R, Davison JM. Is normalisation of serum potassium and magnesium always necessary in Gitelman Syndrome for a successful obstetric outcome?. BJOG: An International Journal of Obstetrics and Gynaecology 2004, 111(6), 630-634.
• Arun CS, Pandit R, Taylor R. Long-term progression of retinopathy after initiation of insulin therapy in Type 2 diabetes: An observational study. Diabetologia 2004, 47(8), 1380-1384.
• Dashora UK, Taylor R. Maintaining glycaemic control during high-dose prednisolone administration for hyperemesis gravidarum in Type 1 diabetes. Diabetic Medicine 2004, 21(3), 298-299.
• Carey PE, Halliday J, Snaar JEM, Morris PG, Taylor R. Direct assessment of muscle glycogen storage after mixed meals in normal and type 2 diabetic subjects. American Journal of Physiology - Endocrinology and Metabolism 2003, 284(4), E688-E694.
• Arun CS, Ngugi N, Lovelock L, Taylor R. Effectiveness of screening in preventing blindness due to diabetic retinopathy. Diabetic Medicine 2003, 20(3), 186-190.
• Harding S, Greenwood R, Aldington S, Gibson J, Owens D, Taylor R, Kohner E, Scanlon P, Leese G. Grading and disease management in national screening for diabetic retinopathy in England and Wales. Diabetic Medicine 2003, 20(12), 965-971.
• Taylor R, Shulman GI. Magnetic resonance spectroscopy studies of liver and muscle glycogen metabolism in humans. In: Kahn, R, ed. Joslin's Diabetes Mellitus. Philadelphia, Pennsylvania, USA; London, UK: Lippincott Williams & Wilkins, 2003, pp.195-206.
• Taylor R, Mirsky S. Screening for diabetic retinopathy. Lancet 2003, 361(9368), 1570.
• Taylor R. Screening for diabetic retinopathy. Lancet 2003, 361(9368), 1570-1570.
• Arun CS, Pandit R, Taylor R. To what extent does initiation of insulin therapy worsen retinopathy in Type 2 diabetes?. In: Diabetologia: 18th Congress of the International Diabetes Federation. 2003, Paris, France: Springer.
• Taylor R, Muhlhauser I, Sleight P, Pogue J, Yusuf S. Blood pressure and cardiovascular risk in the HOPE study. Lancet 2002, 359(9323), 2117-2118.
• Taylor R, Lee C, Kyne-Grzebalski D, Marshall SM, Davison JM. Clinical outcomes of pregnancy in women with type 1 diabetes. Obstetrics and Gynecology 2002, 99(4), 537-541.
• Taylor R, Lee C, Kyne-Grzebalski D, Marshall SM, Davison JM. Clinical outcomes of pregnancy in women with Type 1 diabetes: a single center study of 109 pregnancies. American Journal of Obstetrics & Gynecology 2002, 99(4), 537-541.
• Barnett AH, Taylor R. Interpretation of the HOPE study. Practical Diabetes International 2002, 19(1), 30-31.
• Moran P, Taylor R. Management of hyperemesis gravidarum: the importance of weight loss as a criterion for steroid therapy. QJM 2002, 95(3), 153-158.
• Singhal P, Caumo A, Carey PE, Cobelli C, Taylor R. Regulation of endogenous glucose production after a mixed meal in type 2 diabetes. American Journal of Physiology - Endocrinology and Metabolism 2002, 283(2), E275-E283.
• Rutter MK, Wilcox E, Easton J, Skinner J, Taylor R. Baseline clinical profile and rapid progression to insulin treatment in newly diagnosed diabetic patients over 50 years of age. Practical Diabetes International 2001, 18(3), 99-101.
• Daggett P, Taylor R. Comment on the HOPE study - Reply from Professor Roy Taylor. Practical Diabetes International 2001, 18(9), 338.
• Carey PE, Snaar JEM, Gerrard J, Morris P, Taylor R. Diurnal change in muscle glycogen in type 2 diabetes and in normal subjects. In: 37th Annual Meeting of the EASD. 2001, Glasgow, UK: Springer.
• Halse R, Pearson SL, McCormack JG, Yeaman SJ, Taylor R. Effects of tumor necrosis factor-α on insulin action in cultured human muscle cells. Diabetes 2001, 50(5), 1102-1109.
• Lovelock L, Young D, Shotton M, Taylor R. High resolution digital retinal camera: Does use of two images per eye increase screening time?. In: 37th Annual Meeting of the EASD. 2001, Glasgow, UK: Springer.
• Rutter MK, Wilcox E, Easton J, Skinner J, Taylor R. Improving the early management of blood glucose in emergency admissions with chest pain. Practical Diabetes International 2001, 18(3), 75-78.
• Taylor R, Shulman GI. Regulation of hepatic glucose uptake. In: Jefferson, L.S., Cherrington, A.D, ed. Handbook of Physiology: The Endocrine Pancreas and Regulation of Metabolism. Oxford, UK: Oxford University Press, 2001, pp.787-802.
• Marsden PJ, Murdoch AP, Taylor R. Tissue insulin sensitivity and body weight in polycystic ovary syndrome. Clinical Endocrinology 2001, 55(2), 191-199.
• Marsden PJ, Murdoch AP, Taylor R. Adipocyte insulin action in hypogonadotrophic hypogonadism. Human Reproduction 2000, 15(8), 1672-1678.
• Taylor R, Davies R, Fox C, Sampson M, Weaver JU, Wood L. Appropriate insulin regimes for type 2 diabetes: A multicenter randomized crossover study. Diabetes Care 2000, 23(11), 1612-1618.
• Taylor R, Davies R, Fox C, Sampson M, Weaver JU, Wood L. Appropriate Insulin Regimes for Type 2 Diabetes: a multicenter randomized crossover study. Diabetes Care 2000, 23(11), 1612-1618.
• Singhal P, Barker S, Taylor G, Caumo A, Cobelli C, Taylor R. Control of postprandial hepatic glucose output in type 2 diabetes and matched controls. In: Diabetologia. 2000, Springer.
• Taylor R, Marsden PJ. Insulin sensitivity and fertility. Human Fertility 2000, 3(1), 65-69.
• Pandit RJ, Taylor R. Mydriasis and glaucoma: exploding the myth. A systematic review. Diabetic Medicine 2000, 17(10), 693-699.
• Whittaker PG, Lee CH, Taylor R. Whole body protein kinetics in women: Effect of pregnancy and IDDM during anabolic stimulation. American Journal of Physiology - Endocrinology and Metabolism 2000, 279(5), E978-E988.
• Marsden PJ, Murdoch AP, Taylor R. Adipocyte insulin action following ovulation in polycystic ovarian syndrome. Human Reproduction 1999, 14(9), 2216-2222.
• Carron Brown S, Kyne-Grzebalski D, Mwangi B, Taylor R. Effect of management policy upon 120 Type 1 diabetic pregnancies: Policy decisions in practice. Diabetic Medicine 1999, 16(7), 573-578.
• Kyne-Grzebalski D, Wood L, Marshall SM, Taylor R. Episodic hyperglycaemia in pregnant women with well-controlled Type 1 diabetes mellitus: a major potential factor underlying macrosomia. Diabetic Medicine 1999, 16(8), 702-706.
• Taylor R, Brunetti P. Molecular mechanisms of insulin resistance. Experimental and Clinical Endocrinology and Diabetes 1999, 107(2), 111-112.
• Taylor R. The nature of type 2 diabetes: the role for new agents. In: INTERNATIONAL JOURNAL OF CLINICAL PRACTICE. 1999.
• R. Taylor, D. M. Broadbent, R. Greenwood, D. Hepburn, D. R. Owens and H. Simpson. Mobile retinal screening in Britain. Diabetic Medicine 1998, 15, 344-347.
• R. Taylor, G. D. Stainsby and D. L. Richardson. Rupture of the plantar fascia in the diabetic foot leads to toe dorsiflexion deformity. Diabetologia 1998, 41, 1071.
• R. Taylor. Alternatives to the retinal camera - Reply. Diabetic Medicine 1997, 14, 622-622.
• P. J. Marsden, A. Murdoch and R. Taylor. Adipocyte insulin action during the normal menstrual cycle. Human Reproduction 1996, 11, 968-974.
• A. Gascoigne, A. Appleton, R. Taylor, A. Batchelor and S. Cook. Catastrophic circulatory collapse following re-expansion pulmonary oedema. Resuscitation 1996, 31, 265-269.
• J. M. Webster and R. Taylor. Direct action of gliclazide on skeletal muscle carbohydrate metabolism. Diabetes Nutrition & Metabolism 1996, 9, 115-121.
• R. Taylor, I. Magnusson, D. L. Rothman, G. W. Cline, A. Caumo, C. Cobelli and G. I. Shulman. Direct assessment of liver glycogen storage by C-13 nuclear magnetic resonance spectroscopy and regulation of glucose homeostasis after a mixed meal in normal subjects. Journal of Clinical Investigation 1996, 97, 126-132.
• A. B. Johnson and R. Taylor. Does suppression of postprandial blood glucose excursions by the alpha-glucosidase inhibitor miglitol improve insulin sensitivity in diet-treated type II diabetic patients?. Diabetes Care 1996, 19, 559-563.
• F. Ofei, S. Hurel, J. Newkirk, M. Sopwith and R. Taylor. Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes 1996, 45, 881-885.
• Phillips D.I.W., Borthwick A.C., Stein C., Taylor R. Fetal growth and insulin resistance in adult life: Relationship between glycogen synthase activity in adult skeletal muscle and birthweight. Diabetes Medicine 1996, 13, 325-329.
• R. Taylor. Insulin resistance: Circumventing nature's blocks. Lancet 1996, 348, 1045-1046.
• D. I. W. Phillips, S. Caddy, V. Ilic, B. A. Fielding, K. N. Frayn, A. C. Borthwick and R. Taylor. Intramuscular triglyceride and muscle insulin sensitivity: Evidence for a relationship in nondiabetic subjects. Metabolism-Clinical and Experimental 1996, 45, 947-950.
• R. Taylor, B. A. Hopper, D. Dodgson, P. J. Ohare, R. McCann, P. A. Harte, P. Bell, D. A. Ellingford, R. Newton, D. Taylor, J. E. Tooke, J. Jacobs, H. Hempstead, C. Fernandez, S. RiceEdwards, C. Johnston, S. Fothergill, M. Balshaw, C. Walton, D. M. Broadbent, S. P. Harding, R. Jackson, J. Vora, T. L. Lovelock, K. P. Stannard, M. Flatman, R. Greenwood, G. Peck, W. Jeffcoate, C. Soper, A. Mottram, J. Leadbeatter and H. Simpson. Practical community screening for diabetic retinopathy using the mobile retinal camera: Report of a 12 centre study. Diabetic Medicine 1996, 13, 946-952.
• R. Taylor. Successful management of hyperemesis gravidarum using steroid therapy. Qjm-Monthly Journal of the Association of Physicians 1996, 89, 103-107.
• SPIRO JG, SCOTT S, MACMILLAN J, DIFFEY BL, HINDSON TC, TAYLOR R, TAYLOR AEM, DOWNEY A. TREATMENT OF UREMIC PRURITUS WITH BLUE-LIGHT. PHOTODERMATOLOGY 1985, 2(5), 319-321.
• TAYLOR R, TAYLOR AEM, DIFFEY BL, HINDSON TC. A PLACEBO-CONTROLLED TRIAL OF UV-A PHOTOTHERAPY FOR THE TREATMENT OF UREMIC PRURITUS. NEPHRON 1983, 33(1), 14-16.